Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MLS MEDICAL A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8%   Bankruptcy risk   1.2% 0.8% 1.0% 1.1% 1.8% 1.7% 10.4% 6.1%   Credit score (0-100)   83 92 86 84 69 72 23 13   Credit rating   BBB A A BBB BBB BBB B BB   Credit limit (kDKK)   135.3 601.6 374.4 340.6 3.3 6.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,541 5,114 4,717 4,178 3,545 3,769 0.0 0.0   EBITDA   1,070 984 974 930 367 477 0.0 0.0   EBIT   177 469 413 346 -224 -142 0.0 0.0   Pre-tax profit (PTP)   144.1 405.9 339.5 307.2 -243.7 -221.3 0.0 0.0   Net earnings   119.6 322.2 268.8 242.6 -187.6 -172.3 0.0 0.0   Pre-tax profit without non-rec. items   144 406 339 307 -244 -221 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   2,647 2,564 2,313 1,921 1,820 1,201 0.0 0.0   Shareholders equity total   4,755 5,077 4,845 4,888 4,700 4,528 3,528 3,528   Interest-bearing liabilities   37.9 156 77.9 159 102 80.2 0.0 0.0   Balance sheet total (assets)   7,826 6,827 6,579 6,571 6,087 6,054 3,528 3,528   Net Debt   -1,691 -2,250 -2,839 -3,253 -2,686 -2,931 -3,528 -3,528     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,541 5,114 4,717 4,178 3,545 3,769 0.0 0.0   Gross profit growth   -29.0% -7.7% -7.8% -11.4% -15.2% 6.3% -100.0% 0.0%   Employees   9 8 8 5 5 5 0 0   Employee growth %   -10.0% -11.1% 0.0% -37.5% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,826 6,827 6,579 6,571 6,087 6,054 3,528 3,528   Balance sheet change%   -16.6% -12.8% -3.6% -0.1% -7.4% -0.5% -41.7% 0.0%   Added value   177.1 469.0 413.2 346.3 -224.4 -142.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,768 -597 -812 -975 -692 -1,239 -1,201 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.2% 9.2% 8.8% 8.3% -6.3% -3.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.6% 6.8% 6.5% 6.2% -2.8% -1.8% 0.0% 0.0%   ROI %   3.7% 9.6% 8.2% 7.8% -3.5% -2.2% 0.0% 0.0%   ROE %   2.4% 6.6% 5.4% 5.0% -3.9% -3.7% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   72.6% 78.8% 76.7% 78.1% 85.0% 78.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -158.1% -228.7% -291.5% -349.8% -732.5% -614.1% 0.0% 0.0%   Gearing %   0.8% 3.1% 1.6% 3.3% 2.2% 1.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.2% 97.7% 81.7% 83.7% 51.8% 126.2% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   3.2 3.6 3.3 3.8 6.1 4.1 0.0 0.0   Current Ratio   1.8 2.7 2.7 3.0 3.4 3.3 0.0 0.0   Cash and cash equivalent   1,729.3 2,406.6 2,917.1 3,411.8 2,787.8 3,011.3 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,159.7 2,590.7 2,599.0 2,997.5 2,858.4 3,217.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   20 59 52 69 -45 -28 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   119 123 122 186 73 95 0 0   EBIT / employee   20 59 52 69 -45 -28 0 0   Net earnings / employee   13 40 34 49 -38 -34 0 0